BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22836805)

  • 21. Genomic landscape of pleural and peritoneal mesothelioma tumours.
    Hiltbrunner S; Fleischmann Z; Sokol ES; Zoche M; Felley-Bosco E; Curioni-Fontecedro A
    Br J Cancer; 2022 Nov; 127(11):1997-2005. PubMed ID: 36138075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
    Sato H; Soh J; Aoe K; Fujimoto N; Tanaka S; Namba K; Torigoe H; Shien K; Yamamoto H; Tomida S; Tao H; Okabe K; Kishimoto T; Toyooka S
    Int J Oncol; 2019 Jun; 54(6):2139-2148. PubMed ID: 30942424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
    Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
    Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
    Klebe S; Mahar A; Henderson DW; Roggli VL
    Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
    Wu D; Hiroshima K; Matsumoto S; Nabeshima K; Yusa T; Ozaki D; Fujino M; Yamakawa H; Nakatani Y; Tada Y; Shimada H; Tagawa M
    Am J Clin Pathol; 2013 Jan; 139(1):39-46. PubMed ID: 23270897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
    Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
    Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.
    Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Nonomura A
    Pathol Int; 2012 Apr; 62(4):226-31. PubMed ID: 22449226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathohistological diagnosis and differential diagnosis.
    Tischoff I; Neid M; Neumann V; Tannapfel A
    Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
    Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
    Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
    Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
    Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
    Pavlisko EN; Roggli VL
    Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1.
    Zaleski M; Kalhor N; Fujimoto J; Wistuba I; Moran CA
    Pathol Res Pract; 2020 Dec; 216(12):153267. PubMed ID: 33176261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.
    Fujii M; Fujimoto N; Hiraki A; Gemba K; Aoe K; Umemura S; Katayama H; Takigawa N; Kiura K; Tanimoto M; Kishimoto T
    Cancer Sci; 2012 Mar; 103(3):510-4. PubMed ID: 22146010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.
    Crispi S; Cardillo I; Spugnini EP; Citro G; Menegozzo S; Baldi A
    Curr Cancer Drug Targets; 2010 Feb; 10(1):19-26. PubMed ID: 20088796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
    Alì G; Borrelli N; Riccardo G; Proietti A; Pelliccioni S; Niccoli C; Boldrini L; Lucchi M; Mussi A; Fontanini G
    J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localized malignant mesothelioma.
    Allen TC; Cagle PT; Churg AM; Colby TV; Gibbs AR; Hammar SP; Corson JM; Grimes MM; Ordonez NG; Roggli V; Travis WD; Wick MR
    Am J Surg Pathol; 2005 Jul; 29(7):866-73. PubMed ID: 15958850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP.
    Dote H; Tsukuda K; Toyooka S; Yano M; Pass HI; Shimizu N
    Oncol Rep; 2004 Feb; 11(2):361-3. PubMed ID: 14719068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.